The supply disruption of these products is caused by a combination of manufacturing issues and an increased global demand.
The drugs affected are: methylphenidate, lisdexamfetamine, guanfacine and atomoxetine.
Other ADHD products remain available but cannot meet excessive increases in demand.
At present, the supply disruptions are expected to resolve at various dates between October and December 2023.
Check how much stock you have remaining at home and ask your pharmacist if they have supplies secured. You may need to ask around several pharmacies.
We may need to contact your specialist for advice on what to change your medicines to. If you are still in regular contact with your psychiatrist then it may be more efficient for you to ask them. If not, we will contact them. There may be some delay hearing back from them.